Results 91 to 100 of about 3,280 (212)

Knockout of SAFA reduces immune responses induced by SFTSV infection.

open access: yes, 2021
(A) Knockout of SAFA in THP-1 cells and MEF cells, identified by Western blot. (B-C) WT and SAFA-/- MEF cells were infected with SFTSV (MOI = 10) for 48 h, IFNβ mRNA level was detected by RT-PCR (B), IFNβ cytokine levels were analyzed by ELISA (C).
Xue-jie Yu (523802)   +2 more
core   +1 more source

SFTSV nucleoprotein mediates DNA sensor cGAS degradation to suppress cGAS-dependent antiviral responses

open access: yesMicrobiology Spectrum
Cyclic GMP-AMP synthase (cGAS) is an important DNA pattern recognition receptor that senses double-stranded DNA derived from invading pathogens or self DNA in cytoplasm, leading to an antiviral interferon response.
Ze-zheng Jiang   +9 more
doaj   +1 more source

A Novel Machine Learning Approach for Predicting Prognosis of SFTS Patients in the Early Stages of Disease

open access: yesCanadian Journal of Infectious Diseases and Medical Microbiology, Volume 2026, Issue 1, 2026.
Objective Severe fever with thrombocytopenia syndrome (SFTS) is an emerging tick‐borne disease characterized by high morbidity and mortality rates. Timely detection and prognosis prediction are critical for implementing effective clinical interventions.
Siqi Li   +9 more
wiley   +1 more source

Seroprevalence of SFTSV in healthy human volunteers in Laizhou.

open access: yes, 2016
Seroprevalence of SFTSV in healthy human volunteers in Laizhou.
Mifang Liang (158706)   +11 more
core   +1 more source

Interferon-γ-Directed Inhibition of a Novel High-Pathogenic Phlebovirus and Viral Antagonism of the Antiviral Signaling by Targeting STAT1

open access: yesFrontiers in Immunology, 2019
Severe fever with thrombocytopenia syndrome (SFTS) is a life-threatening infectious disease caused by a novel phlebovirus, SFTS virus (SFTSV). Currently, there is no vaccine or antiviral available and the viral pathogenesis remains largely unknown.
Yun-Jia Ning   +12 more
doaj   +1 more source

Integration of SFTSV Viral Load, Age, and Double‐Negative B‐Cells as Prognostic Biomarkers for Severe Fever With Thrombocytopenia Syndrome Outcomes

open access: yesJournal of Immunology Research, Volume 2026, Issue 1, 2026.
Background Severe fever with thrombocytopenia syndrome (SFTS) is a tick‐borne viral illness with high mortality, yet early risk stratification remains challenging. Recent evidence suggests that B‐cell dysregulation contributes to disease severity. Methods A cohort of 168 patients with confirmed SFTS was retrospectively analyzed. Flow cytometry was used
Wei Wei   +10 more
wiley   +1 more source

Analysis of Gene Differences Between F and B Epidemic Lineages of Bandavirus Dabieense

open access: yesMicroorganisms
The prevalence of SFTS is becoming increasingly widespread and is expected to become a significant security issue. The article discusses the prevalence regions and genetic differences in two SFTSV lineages, so as to provide a scientific data basis for ...
Wenzhou Ma   +6 more
doaj   +1 more source

T Follicular Helper Cell Immune Signatures Associated With Disease Severity in Severe Fever With Thrombocytopenia Syndrome

open access: yesJournal of Immunology Research, Volume 2026, Issue 1, 2026.
Background Severe fever with thrombocytopenia syndrome (SFTS) is marked by high case fatality and profound antiviral immune dysregulation, yet the clinical implications of changes in circulating T follicular helper (Tfh) cells remain unclear. Methods We enrolled 79 patients with RT‐PCR‐confirmed SFTSV infection who were hospitalized from May to October
Danning Xu   +9 more
wiley   +1 more source

Novel Bunyavirus in Domestic and Captive Farmed Animals, Minnesota, USA

open access: yesEmerging Infectious Diseases, 2014
Roger S. Nasci   +3 more
doaj   +3 more sources

Development of recombinant vaccine against Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) [PDF]

open access: yes, 2020
학위논문 (석사) -- 서울대학교 대학원 : 의과대학 의과학과, 2020. 8. 조남혁.Severe Fever with Thrombocytopenia Syndrome virus (SFTSV) is an emerging tick-borne virus which causes SFTS disease with a mortality rate of 5-27% in humans.
최훈철
core  

Home - About - Disclaimer - Privacy